It has been defined by the lack of expression (<1%) of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2), and has a poorer prognosis and worst 5-year relative survival rate compared to other BC subtypes [2,3]. Here, ESR1 is linked to breast cancer.